Research & Development



  曹襄斷然拒絕道︰“你要是也去,我好歹還能同意,跟著去病作戰,我怕我活不過明年。”   “完善他!”av人人视频超碰在线看   雲瑯幽怨的道︰“您也知道,最近家里送來了二十三個腸癰病人,她們兩個為了這些病人都快要打起來了,那個願意留在家里喲。”夜射猫精品在线av   還是老習慣,雲瑯剛要開口說話,公孫弘就擺手拒絕了,冷冷的道︰“行為不檢,會招來殺身之禍,貪戀人家美色,如今自入彀中,讓人驅使如馭牛馬,怨得誰來?”   甦稚擺擺手嘆口氣道︰“也罷,外面的藥快沒有了,總不能再讓家里貼補,再這麼下去我也沒臉見我夫君了。”啪啪网   雲瑯點點頭表示知道,然後就回頭瞅著甦稚道︰“又怎麼了,能把你師姐氣成這樣,估計不是小事。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo